Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InflaRx (IFRX) Net Income towards Common Stockholders (2022 - 2025)

Historic Net Income towards Common Stockholders for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to -$10.6 million.

  • InflaRx's Net Income towards Common Stockholders rose 3414.13% to -$10.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$47.4 million, marking a year-over-year increase of 1734.05%. This contributed to the annual value of -$49.9 million for FY2024, which is 860.33% down from last year.
  • As of Q3 2025, InflaRx's Net Income towards Common Stockholders stood at -$10.6 million, which was up 3414.13% from -$14.0 million recorded in Q2 2025.
  • In the past 5 years, InflaRx's Net Income towards Common Stockholders registered a high of $495.4 billion during Q1 2023, and its lowest value of -$16.6 million during Q1 2022.
  • Its 4-year average for Net Income towards Common Stockholders is $46.9 billion, with a median of -$10.8 million in 2023.
  • Over the last 5 years, InflaRx's Net Income towards Common Stockholders had its largest YoY gain of 298146301.83% in 2023, and its largest YoY loss of 79767.91% in 2023.
  • InflaRx's Net Income towards Common Stockholders (Quarter) stood at -$7.5 million in 2022, then crashed by 74.2% to -$13.1 million in 2023, then increased by 26.13% to -$9.7 million in 2024, then fell by 8.68% to -$10.6 million in 2025.
  • Its Net Income towards Common Stockholders was -$10.6 million in Q3 2025, compared to -$14.0 million in Q2 2025 and -$13.2 million in Q1 2025.